SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 252 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $21,013,000 | -63.5% | 121,598 | -75.7% | 0.02% | -63.6% |
| Q4 2014 | $57,621,000 | +935.0% | 501,317 | +1307.0% | 0.06% | +816.7% |
| Q3 2014 | $5,567,000 | +28.1% | 35,629 | +1.1% | 0.01% | +50.0% |
| Q2 2014 | $4,345,000 | +20.1% | 35,229 | +0.9% | 0.00% | 0.0% |
| Q1 2014 | $3,619,000 | -92.6% | 34,929 | -93.6% | 0.00% | -92.9% |
| Q4 2013 | $49,162,000 | +19.6% | 546,608 | -11.0% | 0.06% | +9.8% |
| Q3 2013 | $41,097,000 | -18.7% | 614,489 | -19.6% | 0.05% | -21.5% |
| Q2 2013 | $50,578,000 | – | 764,595 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |